The Global Autoimmune Disease Diagnostics Market is estimated to be USD 4.98 Bn in 2021 and is expected to reach USD 7.84 Bn by 2026, growing at a CAGR of 9.5%.
Market Dynamics
The increasing prevalence of autoimmune diseases such as arthritis, inflammatory bowel disease, multiple sclerosis, diabetes type 1, etc. is the major factor increasing the autoimmune disease diagnostics market. The rising sedentary lifestyle leading to autoimmune diseases, growing healthcare expenditure, and increasing geriatric population have exhibited market growth. Furthermore, government initiatives in the healthcare sector and private companies increasing investment in research and development in autoimmune diseases are anticipated to create new opportunities for the market, globally.
However, the high cost of autoimmune disease diagnostics and low awareness in emerging countries is anticipated to hamper the market growth.
Market Segmentation
The Global Autoimmune Disease Diagnostics Market is segmented further based on Product Type, Diagnostic Tests, Diseases, and Geography.
By Product Type, the market is classified into consumables & assay kits, and instruments. Amongst all, the consumables & assay kits segment is estimated to hold the highest market share during the forecast period.
By Diagnostic Test, the market is classified as routine laboratory tests, inflammatory markers, autoantibodies and immunologic tests, and other tests. Amongst the two, the routine laboratory tests segment is estimated to hold the highest market share during the forecast period.
By Diseases, the market is classified as systemic autoimmune disease diagnostics, and localized autoimmune disease diagnostics. Amongst the two, the localized autoimmune disease diagnostics segment is estimated to hold the highest market share during the forecast period.
By Geography, North America is projected to lead the market.
Recent Developments
1. Thermo Fisher Scientific to Acquire QIAGEN N.V. a leading provider of life science and molecular diagnostic solutions having presence in around 25 countries. - 3rd March 2020.
2. Progentec launched a novel blood test - aiSLE™ DX Flare Risk Index laboratory test that can assess the likelihood of a systemic lupus erythematosus patient experiencing an immunologic disease flare in the ensuing 12 weeks. - 15th September 2020.
Company Profiles
Some of the companies covered in this report Thermo Fisher Scientific Inc, Progentec Diagnostics, Inc., Siemens AG, Abbott Laboratories, Danaher Corporation, Bio-Rad Laboratories, Inc, Grifols, S.A., etc.
Competitive Quadrant
The report includes a Competitive Quadrant, a proprietary tool to analyze and evaluate the position of companies based on their Industry Position score and Market Performance score. The tool uses various factors for categorizing the players into four categories. Some of these factors considered for analysis are financial performance over the last 3 years, growth strategies, innovation score, new product launches, investments, growth in market share, etc.
Why buy this report?
Report Highlights:
Market Dynamics
The increasing prevalence of autoimmune diseases such as arthritis, inflammatory bowel disease, multiple sclerosis, diabetes type 1, etc. is the major factor increasing the autoimmune disease diagnostics market. The rising sedentary lifestyle leading to autoimmune diseases, growing healthcare expenditure, and increasing geriatric population have exhibited market growth. Furthermore, government initiatives in the healthcare sector and private companies increasing investment in research and development in autoimmune diseases are anticipated to create new opportunities for the market, globally.
However, the high cost of autoimmune disease diagnostics and low awareness in emerging countries is anticipated to hamper the market growth.
Market Segmentation
The Global Autoimmune Disease Diagnostics Market is segmented further based on Product Type, Diagnostic Tests, Diseases, and Geography.
By Product Type, the market is classified into consumables & assay kits, and instruments. Amongst all, the consumables & assay kits segment is estimated to hold the highest market share during the forecast period.
By Diagnostic Test, the market is classified as routine laboratory tests, inflammatory markers, autoantibodies and immunologic tests, and other tests. Amongst the two, the routine laboratory tests segment is estimated to hold the highest market share during the forecast period.
By Diseases, the market is classified as systemic autoimmune disease diagnostics, and localized autoimmune disease diagnostics. Amongst the two, the localized autoimmune disease diagnostics segment is estimated to hold the highest market share during the forecast period.
By Geography, North America is projected to lead the market.
Recent Developments
1. Thermo Fisher Scientific to Acquire QIAGEN N.V. a leading provider of life science and molecular diagnostic solutions having presence in around 25 countries. - 3rd March 2020.
2. Progentec launched a novel blood test - aiSLE™ DX Flare Risk Index laboratory test that can assess the likelihood of a systemic lupus erythematosus patient experiencing an immunologic disease flare in the ensuing 12 weeks. - 15th September 2020.
Company Profiles
Some of the companies covered in this report Thermo Fisher Scientific Inc, Progentec Diagnostics, Inc., Siemens AG, Abbott Laboratories, Danaher Corporation, Bio-Rad Laboratories, Inc, Grifols, S.A., etc.
Competitive Quadrant
The report includes a Competitive Quadrant, a proprietary tool to analyze and evaluate the position of companies based on their Industry Position score and Market Performance score. The tool uses various factors for categorizing the players into four categories. Some of these factors considered for analysis are financial performance over the last 3 years, growth strategies, innovation score, new product launches, investments, growth in market share, etc.
Why buy this report?
- The report offers a comprehensive evaluation of the Global Autoimmune Disease Diagnostics Market. The report includes in-depth qualitative analysis, verifiable data from authentic sources, and projections about market size. The projections are calculated using proven research methodologies.
- The report has been compiled through extensive primary and secondary research. The primary research is done through interviews, surveys, and observation of renowned personnel in the industry.
- The report includes an in-depth market analysis using Porter’s 5 forces model and the Ansoff Matrix. In addition, the impact of Covid-19 on the market is also featured in the report.
- The report also includes the regulatory scenario in the industry, which will help you make a well-informed decision. The report discusses major regulatory bodies and major rules and regulations imposed on this sector across various geographies.
- The report also contains a competitive analysis using the Positioning Quadrants, the analyst’s Proprietary competitive positioning tool.
Report Highlights:
- A complete analysis of the market, including parent industry
- Important market dynamics and trends
- Market segmentation
- Historical, current, and projected size of the market based on value and volume
- Market shares and strategies of key players
- Recommendations to companies for strengthening their foothold in the market
Frequently Asked Questions about the Global Autoimmune Disease Diagnostics Market
What is the estimated value of the Global Autoimmune Disease Diagnostics Market?
What is the growth rate of the Global Autoimmune Disease Diagnostics Market?
What is the forecasted size of the Global Autoimmune Disease Diagnostics Market?
Who are the key companies in the Global Autoimmune Disease Diagnostics Market?
Report Attribute | Details |
---|---|
No. of Pages | 186 |
Published | April 2021 |
Forecast Period | 2021 - 2026 |
Estimated Market Value ( USD
| USD 4980 Million |
Forecasted Market Value ( USD
| USD 7840 Million |
Compound Annual Growth Rate | 9.5% |
Regions Covered | Global |
No. of Companies Mentioned | 20 |
Table of Contents
1 Report Description
2 Research Methodology
3 Executive Summary
4 Market Influencers
5 Market Analysis
6 Global Autoimmune Disease Diagnostics Market, By Product Type
7 Global Autoimmune Disease Diagnostics Market, By Diagnostic Tests
8 Global Autoimmune Disease Diagnostics Market, By Diseases
9 Global Autoimmune Disease Diagnostics Market, By Geography
10 Competitive Landscape
11 Company Profiles
12 Appendix
Companies Mentioned
- A. Menarini Diagnostics S.r.l.
- Abbott Laboratories
- AstraZeneca plc
- Beckman Coulter Inc
- Bio-Rad Laboratories, Inc
- Danaher Corporation
- Exagen Inc.
- F. Hoffmann-La Roche
- Grifols, S.A.
- Hemagen Diagnostics Inc.
- HTG Molecular Diagnostics, Inc
- Inova Diagnostics Inc.
- Novartis AG
- Pfizer Inc
- Progentec Diagnostics, Inc.
- Seramun Diagnostica GmbH
- Siemens AG
- Thermo Fisher Scientific Inc
- Trinity Biotech plc
- Werfen